MLICM
NXTC icon

Metropolitan Life Insurance Company (MetLife)’s NextCure NXTC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-426
Closed -$110K – 2583
2020
Q2 		$110K Buy
426
+44
+12% +$16.8K ﹤0.01% 2200
2020
Q1 		$170K Hold
382
– – ﹤0.01% 1682
2019
Q4 		$258K Buy
+382
New +$192K ﹤0.01% 1744

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s NXTC Position: Q3 2020 in Review

Metropolitan Life Insurance Company (MetLife) sold out of NextCure (NXTC) in Q3 2020, closing a stake of 426 shares — an estimated $110K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NXTC in Q4 2019 and held it in 3 quarters. The position peaked at $258K in Q4 2019. 75 funds tracked by Wall St. Rank hold NXTC as of Q3 2020.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining NextCure position as of Q3 2020 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 426 NextCure shares in Q3 2020, an estimated $110K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in NextCure in Q4 2019 and held it in 3 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s NextCure position peaked at $258K in Q4 2019.
  • 75 funds tracked by Wall St. Rank held NextCure as of Q3 2020.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2020, filed 13 Nov 2020.